As of 2025-05-06, the EV/EBITDA ratio of Sierra Oncology Inc (SRRA) is -15.47. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SRRA's latest enterprise value is 1,342.82 mil USD. SRRA's TTM EBITDA according to its financial statements is -86.80 mil USD. Dividing these 2 quantities gives us the above SRRA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |